Stride Newsroom

Stride Analyst Ratings

BenzingaApr 26 00:35

BMO Capital Maintains Outperform on Stride, Raises Price Target to $73

BenzingaApr 26 00:35

Barrington Research: Maintaining the Stride (LRN.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $75.00 to $75.00.

Zhitong FinanceApr 24 21:51

Barrington Research Maintains Outperform on Stride, Maintains $75 Price Target

BenzingaApr 24 21:51

Stride Analyst Ratings

BenzingaApr 24 21:50

Morgan Stanley Raises Price Target on Stride to $70 From $65, Cites 'Solid Quarter,' Keeps Equalweight Rating

MT NewswiresApr 24 19:17

Barrington Research: Maintaining the Stride (LRN.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $75.00 to $75.00.

Zhitong FinanceApr 17 22:01

Stride Analyst Ratings

BenzingaApr 17 22:00

Buy Rating Justified for Stride Inc. on Strong Market Position and Growth Prospects in Virtual Education

TipRanksMar 28 19:21

Citigroup Maintains Buy on Stride, Raises Price Target to $75

BenzingaJan 30 05:08

Stride Analyst Ratings

BenzingaJan 30 05:06

BMO Capital Maintains Outperform on Stride, Raises Price Target to $72

BenzingaJan 25 22:57

Stride Analyst Ratings

BenzingaJan 25 22:56

Barrington Ups Price Target on Stride to $75 From $70 as Fiscal Q2 Results Surpass Estimates, Maintains Outperform Rating

MT NewswiresJan 25 20:48

Stride (LRN) Outpaces Expectations: A Comprehensive Buy Rating Justification

TipRanksJan 25 20:38

Barrington Research Maintains Outperform on Stride, Raises Price Target to $75

BenzingaJan 25 00:09

Stride Analyst Ratings

BenzingaJan 25 00:05

Stride, Inc. Outperforms With Strong Financial Results and Undervalued Stock: A Buy Rating Reaffirmed

TipRanksJan 24 22:45

Hold Rating and Lowered Price Target for Reneo Pharmaceuticals Following STRIDE Study Setback and Operational Challenges

TipRanksDec 15, 2023 17:46

What 6 Analyst Ratings Have To Say About Stride

BenzingaDec 5, 2023 02:00